Precigen Stock Current Valuation
| PGEN Stock | USD 1.81 0.01 0.56% |
Valuation analysis of Precigen helps investors to measure Precigen's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 23rd of March 2025, Enterprise Value Over EBITDA is likely to drop to -2.42. In addition to that, Enterprise Value Multiple is likely to drop to -2.42. Fundamental drivers impacting Precigen's valuation include:
Overvalued
Today
Please note that Precigen's price fluctuation is extremely dangerous at this time. Calculation of the real value of Precigen is based on 3 months time horizon. Increasing Precigen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Precigen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Precigen Stock. However, Precigen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.81 | Real 1.34 | Target 5.33 | Hype 1.81 | Naive 2.03 |
The intrinsic value of Precigen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Precigen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Precigen helps investors to forecast how Precigen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Precigen more accurately as focusing exclusively on Precigen's fundamentals will not take into account other important factors: Precigen Company Current Valuation Analysis
Precigen's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Precigen Current Valuation | 439.81 M |
Most of Precigen's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Precigen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Precigen Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Precigen is extremely important. It helps to project a fair market value of Precigen Stock properly, considering its historical fundamentals such as Current Valuation. Since Precigen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Precigen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Precigen's interrelated accounts and indicators.
Click cells to compare fundamentals
Precigen Current Valuation Historical Pattern
Today, most investors in Precigen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Precigen's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Precigen current valuation as a starting point in their analysis.
Precigen Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Precigen has a Current Valuation of 439.81 M. This is 96.94% lower than that of the Biotechnology sector and 90.53% lower than that of the Health Care industry. The current valuation for all United States stocks is 97.35% higher than that of the company.
Precigen Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Precigen's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Precigen could also be used in its relative valuation, which is a method of valuing Precigen by comparing valuation metrics of similar companies.Precigen is currently under evaluation in current valuation category among its peers.
Precigen Current Valuation Drivers
We derive many important indicators used in calculating different scores of Precigen from analyzing Precigen's financial statements. These drivers represent accounts that assess Precigen's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Precigen's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 844.7M | 1.7B | 304.5M | 327.7M | 309.0M | 293.5M | |
| Enterprise Value | 1.0B | 1.8B | 351.1M | 327.2M | 285.0M | 270.7M |
Precigen Fundamentals
| Return On Equity | -1.61 | ||||
| Return On Asset | -0.4 | ||||
| Operating Margin | (19.11) % | ||||
| Current Valuation | 439.81 M | ||||
| Shares Outstanding | 294.04 M | ||||
| Shares Owned By Insiders | 9.97 % | ||||
| Shares Owned By Institutions | 66.15 % | ||||
| Number Of Shares Shorted | 19.05 M | ||||
| Price To Earning | (2.06) X | ||||
| Price To Book | 13.82 X | ||||
| Price To Sales | 135.60 X | ||||
| Revenue | 3.92 M | ||||
| Gross Profit | (53.41 M) | ||||
| EBITDA | (123.5 M) | ||||
| Net Income | (126.23 M) | ||||
| Cash And Equivalents | 115.3 M | ||||
| Cash Per Share | 0.55 X | ||||
| Total Debt | 5.5 M | ||||
| Debt To Equity | 3.73 % | ||||
| Current Ratio | 5.51 X | ||||
| Book Value Per Share | 0.13 X | ||||
| Cash Flow From Operations | (68.17 M) | ||||
| Short Ratio | 9.69 X | ||||
| Earnings Per Share | (0.47) X | ||||
| Price To Earnings To Growth | (1.52) X | ||||
| Target Price | 6.39 | ||||
| Beta | 1.58 | ||||
| Market Capitalization | 532.22 M | ||||
| Total Asset | 145.27 M | ||||
| Retained Earnings | (2.09 B) | ||||
| Working Capital | 80.9 M | ||||
| Current Asset | 285.72 M | ||||
| Current Liabilities | 66.91 M | ||||
| Net Asset | 145.27 M |
About Precigen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Precigen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Precigen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Precigen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Precigen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precigen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will appreciate offsetting losses from the drop in the long position's value.Moving together with Precigen Stock
Moving against Precigen Stock
| 0.84 | CRNX | Crinetics Pharmaceuticals | PairCorr |
| 0.8 | SCLX | Scilex Holding | PairCorr |
| 0.75 | CDIO | Cardio Diagnostics | PairCorr |
| 0.74 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
| 0.69 | CDIOW | Cardio Diagnostics | PairCorr |
The ability to find closely correlated positions to Precigen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precigen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precigen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precigen to buy it.
The correlation of Precigen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precigen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precigen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Precigen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Precigen Piotroski F Score and Precigen Altman Z Score analysis. To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.